ProCE Banner Activity

Managing Patients With High-Risk Hepatocellular Carcinoma: Critical Considerations for the Interdisciplinary Team


Download these slides for a comprehensive overview of current and emerging therapies for high-risk HCC.

Released: January 30, 2024



Amit Singal

Amit Singal, MD, MS

Professor of Medicine
Chief of Hepatology
Director of Liver Tumor Program
UT Southwestern Medical Center
Dallas, Texas

Mark Yarchoan

Mark Yarchoan, MD

Associate Professor
Division of GI Malignancies
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from Genentech, a member of the Roche Group.

Genentech, a member of the Roche Group